|
Jury Sides With Novartis in Generic Famvir Patent Case
Novartis has won a patent dispute in a district court with Teva Pharmaceutical Industries over the antiviral drug Famvir, which could make Teva liable
for damages due to its short-lived at-risk 2007 launch of a generic version.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives